Preoperative Venous Collapsibility Indices and Post-Induction Hypotension in Patients Undergoing Elective Isolated Coronary Artery Bypass Grafting
Association Between Preoperative Venous Collapsibility Indices and Post-Induction Hypotension in Patients Undergoing Elective Isolated Coronary Artery Bypass Grafting: A Prospective Observational Study
This study will examine whether changes in the size of three large veins during normal breathing are associated with low blood pressure shortly after general anaesthesia begins in adults scheduled for planned coronary artery bypass surgery.
Before anaesthesia, a researcher will use ultrasound to measure how much the three veins narrow and widen as each participant breathes normally. The research team will then monitor blood pressure during the first 10 minutes after anaesthesia begins. The study hypothesis is that the amount of change in vein size is associated with the likelihood of low blood pressure during this period. The team will compare how well the three measurements distinguish between participants who develop low blood pressure and those who do not. The ultrasound results will not be used to guide anaesthesia or treatment.
Studieoversikt
Status
Status
Forhold
Forhold
Intervensjon / Behandling
Intervensjon / Behandling
Detaljert beskrivelse
This single-centre, prospective observational cohort study will be conducted at the Institute of Cardiology, Istanbul University-Cerrahpasa. Adults scheduled for elective isolated coronary artery bypass grafting will be enrolled consecutively.
A single investigator will perform all ultrasound examinations before any sedative or anaesthetic medication is administered. Participants will lie supine with the head in a neutral position and breathe quietly without assistance. The right internal jugular vein, right subclavian vein and inferior vena cava will be assessed in each participant. For each vein, the maximum and minimum internal anteroposterior diameters will be measured using M-mode ultrasound over three separate respiratory cycles. The collapsibility index for each cycle will be calculated by subtracting the minimum diameter from the maximum diameter, dividing the difference by the maximum diameter and multiplying by 100. The mean of the three cycle-specific indices will be used for each vein. The vein and the reason for any technically inadequate measurement will be recorded.
Invasive arterial pressure will be monitored continuously during the observation period. Baseline mean arterial pressure will be calculated as the average of three stable readings obtained one minute apart before any sedative or anaesthetic medication is administered. The start of intravenous fentanyl administration will mark the start of induction and the beginning of the 10-minute observation period. The anaesthetist performing induction will be unaware of the ultrasound results. The attending anaesthetist will determine perioperative management and treatment according to clinical judgement.
The association between each venous collapsibility index and post-induction hypotension will be assessed in a separate logistic regression model. Discrimination will be evaluated using the area under the receiver operating characteristic curve. The three areas will be compared using the paired DeLong test in participants with valid measurements for all three veins.
Studietype
Studietype
Registrering (Antatt)
Registrering
Kontakter og plasseringer
Studiekontakt
Studiekontakt
- Navn: Gozde Altun
- Telefonnummer: +905544290333
- E-post: gozde.altun@iuc.edu.tr
Deltakelseskriterier
Kvalifikasjonskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Prøvetakingsmetode
Studiepopulasjon
The study population will consist of adults scheduled for elective isolated coronary artery bypass grafting at the Institute of Cardiology, Istanbul University-Cerrahpaşa, Istanbul, Türkiye. Patients will be screened consecutively during the study period. Those who meet the eligibility criteria and provide written informed consent will be enrolled.
Beskrivelse
Inclusion Criteria:
- Age 18 years or older.
- Scheduled for elective isolated coronary artery bypass grafting.
- Provides written informed consent.
Exclusion Criteria:
- Urgent or emergency surgery.
- Planned concomitant cardiac surgery in addition to coronary artery bypass grafting.
- Left ventricular ejection fraction below 40% on preoperative transthoracic echocardiography.
- Tricuspid annular plane systolic excursion (TAPSE) of 17 mm or less, or severe right ventricular systolic dysfunction on preoperative echocardiographic assessment.
- Severe or greater tricuspid regurgitation.
- Haemodynamic instability requiring vasopressor or inotropic support before induction of anaesthesia.
- Known thrombosis in a vein selected for ultrasound assessment or an indwelling catheter that interferes with the planned measurement.
- Inability to assume the position required for venous ultrasonography.
- No reliable ultrasound measurements can be obtained from the three target veins during quiet spontaneous breathing.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Observasjonsmodeller: COHORT
- Tidsperspektiver: PROSPECTIVE
Antall grupper / kohorter
Kohorter og intervensjoner
Gruppe / KohortGruppe / Kohort |
Intervensjon / BehandlingIntervensjon / Behandling |
|---|---|
|
Adults Undergoing Elective Isolated Coronary Artery Bypass Grafting
Adults scheduled for elective isolated coronary artery bypass grafting will undergo venous ultrasound before induction of general anaesthesia. Collapsibility indices will be measured in the right internal jugular vein, right subclavian vein and inferior vena cava during quiet spontaneous breathing. Participants will be observed for hypotension during the first 10 minutes after induction begins. The ultrasound findings will be used for research analysis. |
Bedside M-mode ultrasonography will be performed before administration of any sedative or anaesthetic medication. The collapsibility index for each vein will be calculated from diameter changes during three quiet spontaneous respiratory cycles. The ultrasound findings will not be used to guide anaesthesia or treatment. |
Hva måler studien?
Primære resultatmål
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Proportion of Participants With Post-Induction Hypotension
Tidsramme: Within the first 10 minutes from the start of intravenous fentanyl administration for induction of general anaesthesia.
|
Proportion of participants who experience at least one episode of hypotension during the first 10 minutes after induction of general anaesthesia begins. Hypotension is defined as a mean arterial pressure (MAP) below 65 mmHg or a decrease of more than 20% from baseline MAP. Baseline MAP is the mean of three stable invasive arterial pressure readings taken one minute apart before administration of any sedative or anaesthetic medication. Arterial pressure will be monitored continuously. After measurement artefacts have been excluded, any episode meeting either criterion will count, including episodes that resolve rapidly after treatment. |
Within the first 10 minutes from the start of intravenous fentanyl administration for induction of general anaesthesia.
|
Sekundære resultatmål
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Lowest Mean Arterial Pressure
Tidsramme: During the first 10 minutes after the start of intravenous fentanyl administration for induction of general anaesthesia.
|
Lowest artefact-free mean arterial pressure (MAP), in mmHg, recorded by continuous invasive arterial pressure monitoring during the observation period. |
During the first 10 minutes after the start of intravenous fentanyl administration for induction of general anaesthesia.
|
|
Maximum Absolute Decrease in Mean Arterial Pressure
Tidsramme: During the first 10 minutes after the start of intravenous fentanyl administration for induction of general anaesthesia.
|
Baseline mean arterial pressure (MAP) minus the lowest artefact-free MAP recorded during the observation period, expressed in mmHg. |
During the first 10 minutes after the start of intravenous fentanyl administration for induction of general anaesthesia.
|
|
Maximum Percentage Decrease in Mean Arterial Pressure
Tidsramme: During the first 10 minutes after the start of intravenous fentanyl administration for induction of general anaesthesia.
|
Baseline mean arterial pressure (MAP) minus the lowest artefact-free MAP recorded during the observation period, divided by baseline MAP and multiplied by 100. |
During the first 10 minutes after the start of intravenous fentanyl administration for induction of general anaesthesia.
|
|
Proportion of Participants Requiring Vasopressors for Hypotension
Tidsramme: During the first 10 minutes after the start of intravenous fentanyl administration for induction of general anaesthesia.
|
Proportion of participants who receive at least one vasopressor dose to treat hypotension during the observation period. The agent, dose and administration time will be recorded for each administration. |
During the first 10 minutes after the start of intravenous fentanyl administration for induction of general anaesthesia.
|
|
Discrimination of Post-Induction Hypotension by Pre-Induction Venous Collapsibility Indices
Tidsramme: Venous indices measured before induction of general anaesthesia. Hypotension assessed within the first 10 minutes from the start of intravenous fentanyl administration for induction.
|
The area under the receiver operating characteristic curve (AUC) and its 95% confidence interval will be estimated for each pre-induction venous collapsibility index (internal jugular vein, subclavian vein and inferior vena cava) to assess discrimination of post-induction hypotension. AUCs will be compared using the paired DeLong test in participants with valid measurements for all three indices. |
Venous indices measured before induction of general anaesthesia. Hypotension assessed within the first 10 minutes from the start of intravenous fentanyl administration for induction.
|
Samarbeidspartnere og etterforskere
Sponsor
Sponsor
Studierekorddatoer
Studer hoveddatoer
Studiestart (Antatt)
Studiestart
Primær fullføring (Antatt)
Primær fullføring
Studiet fullført (Antatt)
Studiet fullført
Datoer for studieregistrering
Først innsendt
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Først lagt ut
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Sist oppdatering lagt ut
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Andre studie-ID-numre
Andre studie-ID-numre
- 020
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
IPD-planbeskrivelse
There is no current plan to share individual participant data with other researchers.
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .